Patient eligibility for thrombectomy after acute stroke: Northern French Alps database analysis

Rev Neurol (Paris). 2017 Apr;173(4):216-221. doi: 10.1016/j.neurol.2017.03.010. Epub 2017 Apr 1.

Abstract

Background: Since 2015, the emergence of mechanical thrombectomy as standard care in acute stroke has involved organizational changes not only for stroke centers, but also for entire emergency regional networks. The aim of our study was to assess the proportion of ischemic stroke patients, admitted to stroke units in the Northern French Alps within the first 6h of onset, eligible for thrombectomy.

Methods: This study retrospectively analyzed the clinical and radiological data of all acute stroke patients hospitalized at three stroke units of the Northern French Alps Emergency Network (RENAU) in 2014. Eligible patients had proximal arterial occlusions of the anterior and posterior cerebral circulation, as confirmed by brain imaging, which could be treated by thrombectomy within 6h of symptom onset.

Results: Of the 435 cases of acute ischemic stroke, 152 patients were treated by intravenous thrombolysis (IV rtPA). Of these patients, 83 (55%) had intracranial occlusions and were eligible for combined thrombectomy. Of the 283 patients not treatable by IV rtPA, 32 patients (11%) were eligible for primary thrombectomy.

Conclusion: Thrombectomy could be performed in 26% of our acute ischemic stroke patients (n=115/435), and a large increase in endovascular procedures is expected over the next few years that will require close collaboration among all partners in the emergency networks. Using our RENAU stroke database, it will be possible to compare various factors contributing to effective activity.

Keywords: Endovascular recanalization; Epidemiology; Stroke; Stroke registry; Thrombectomy; Thrombolysis.

MeSH terms

  • Aged
  • Brain Ischemia / drug therapy
  • Cerebrovascular Circulation
  • Databases, Factual
  • Eligibility Determination
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • France / epidemiology
  • Humans
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Stroke / drug therapy
  • Stroke / epidemiology
  • Stroke / surgery*
  • Thrombectomy / statistics & numerical data*
  • Thrombolytic Therapy
  • Time-to-Treatment
  • Treatment Outcome

Substances

  • Fibrinolytic Agents